Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.

MLA

Zhang, Helin, et al. “Pan-Cancer Analysis Shows That KIFC2 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.” Molecular Biotechnology, Apr. 2024. EBSCOhost, https://doi.org/10.1007/s12033-024-01149-y.

APA

Zhang, H., Zhang, X., Zhang, Y., Han, D., Ha, H., Zhang, B., & Shang, P. (2024). Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01149-y

Chicago

Zhang, Helin, Xingxing Zhang, Yuelin Zhang, Dali Han, Hualan Ha, Biao Zhang, and Panfeng Shang. 2024. “Pan-Cancer Analysis Shows That KIFC2 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.” Molecular Biotechnology, April. doi:10.1007/s12033-024-01149-y.